Stay updated with breaking news from Michael Cecchini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered with CM24+nivolumab+Nal/IRI/5FU/LV vs. standard-of-care(SoC) based on preliminary interim dataProlongation of
ALBAWABA In a significant stride towards early cancer detection, researchers have developed an innovative AI-powered test capable of identifying three m
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
This symptom is often dismissed, which is why it's so important to recognize.
This symptom is often dismissed, which is why it's so important to recognize.